ng-nitroarginine methyl ester has been researched along with 2019 Novel Coronavirus Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alexander, LM; Dillon, GA; Kenney, WL; Williams, AC; Wolf, ST | 1 |
1 other study(ies) available for ng-nitroarginine methyl ester and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Nitric oxide-mediated cutaneous microvascular function is not altered in middle-aged-to-older adults following mild SARS-CoV-2 infection: A pilot study.
Topics: Aged; COVID-19; Cross-Sectional Studies; Humans; Microdialysis; Middle Aged; NG-Nitroarginine Methyl Ester; Nitric Oxide; Pilot Projects; Regional Blood Flow; SARS-CoV-2; Skin; Vasodilation | 2023 |